Home/Filings/4/0000950170-25-004300
4//SEC Filing

Neal James R 4

Accession 0000950170-25-004300

CIK 0001541157other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 5:30 PM ET

Size

5.0 KB

Accession

0000950170-25-004300

Insider Transaction Report

Form 4
Period: 2025-01-09
Neal James R
Director
Transactions
  • Award

    Ordinary Shares, par value $0.0001 per share

    2025-01-09$0.00/sh+8,000,000$4,80032,216,000 total
Footnotes (2)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
  • [F2]On January 9, 2025, the Reporting Person acquired 8,000,000 Ordinary Shares at a purchase price of $0.00065 per Ordinary Share.

Documents

1 file

Issuer

Akari Therapeutics Plc

CIK 0001541157

Entity typeother

Related Parties

1
  • filerCIK 0001600865

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:30 PM ET
Size
5.0 KB